Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
Date:9/20/2007

SAN DIEGO, Sept. 20 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the corporate overview on Thursday, September 27, 2007 at 11:30 am Eastern Time (8:30 am Pacific Time) during the UBS 2007 Global Life Sciences Conference in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcasts and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, including intravenous acetaminophen (IV acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% aqueous gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Cadence(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Contacts: William R. LaRue Anna Gralinska

SVP & Chief Financial Officer Director, Investor
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...-FirstCall/ -- PharmAthene, Inc.,(NYSE Alternext ...,countermeasures against biological and chemical t...eement with Medison Pharma Ltd., to commercialize ...need for advanced medical countermeasures to comba...r chemical weapons is a significant global,concer...
(Date:11/19/2008)...swire-FirstCall/ -- American,HealthChoice, Inc. (...ce.com , a,medical services company with medical ...ounce the first sales of the U.S. FDA approved Omn...at detects patterns of abnormality within,the hum...revention and,treatment. , "Physicians pur...
(Date:11/19/2008)...ire-FirstCall/ -- Jazz Pharmaceuticals,Inc. (Nas...corporate presentation,planned for today at the L...rence due to the proximity of the release of preli...otal clinical trial of JZP-6 (sodium oxybate) for,...ny anticipates that it will release the preliminar...
(Date:11/19/2008)...r Tengion Neo-Bladder(TM) Franchise , , EAS...Inc. , a clinical stage regenerative medicine comp...eo-tissues, today announced that it has completed ...ing a total of approximately $21 million in additi...stitutional equity investor base along with new in...
Breaking Biology Technology:PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 2PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 3PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 4American HealthChoice Announces the First Sales of the OmniBody Scan 2Tengion Announces Second Closing of Series C Financing 2Tengion Announces Second Closing of Series C Financing 3
... We spend a fair amount of time in Wisconsin celeb... with good reason. Institutions such as the UW-Mad...l and engineering centers churn out world-class id...s "real-time" economy, an economy that responds qu... of a global marketplace. What,s needed in Wiscons...
... a number of reasons, we have all heard a lot abou...rugs, the rise in number of people without medical...overnments efforts to accelerate the entry of gene...g costs of health care are just a few reasons. , ...ans or 14.6 percent of the U.S. population have no...
...- Optical Mapping is a new technology that will be...de effects, or fail to respond to medication and t... virulence in pathogenic organisms. Wisconsin- bas...ts Optical Mapping(TM) system for rapid, cost-effe...man. The system provides a powerful tool for high...
...Governor Jim Doyle today announced his "Grow Wisco...nt. One of the recommendations is to increase broa...in the state. , ,Mike Tye, AT&T regional vice pres...AT&T is encouraged by the "Grow Wisconsin" initiat.... AT&T is committed to enhancing and expanding its...
Other Biology Technology:Building a "Real Time" Economy in Wisconsin 2Building a "Real Time" Economy in Wisconsin 3The Generic Drug Industry in Illinois 2The Generic Drug Industry in Illinois 3The Generic Drug Industry in Illinois 4Whole Genomes From Microbes to Man 2Whole Genomes From Microbes to Man 3
(Date:11/19/2008)...S -- The National Academy of Sciences (NAS) announ...inment Exchange," an initiative designed to connec...ientists and engineers to help the creators of tel...ctions incorporate science into their work. The E...rt to reach out to the entertainment community and...
(Date:11/19/2008)...he latest American Chemical Society (ACS) News Ser...eviewed journals and Chemical & Engineering News ...rican Chemical Society as the source for this info...EXCEPT ARTICLE #5, which is embargoed for 9 a. m.,...LE #1 FOR IMMEDIATE RELEASE , Microcapsules act...
(Date:11/19/2008)...NCE, R.I. [Brown University] Imagine yourself swi...d legs, not the viscosity of the water, that mostl..., For tiny organisms, the situation is different... to the physical vagaries of the fluid around them...ay Tang, associate professor of physics at Brown U...
(Date:11/19/2008)...s largest alliance on agricultural research will c...l scientists, policy makers and donor representati... discuss the best approaches for meeting the food ...haken the global food system to its coreclimate ch...and an explosive worldwide financial crisis. In ju...
Breaking Biology News(10 mins):NAS announces initiative to connect entertainment industry with top experts 2NAS announces initiative to connect entertainment industry with top experts 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 2American Chemical Society's Weekly PressPac -- Nov. 19, 2008 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 4American Chemical Society's Weekly PressPac -- Nov. 19, 2008 5American Chemical Society's Weekly PressPac -- Nov. 19, 2008 6American Chemical Society's Weekly PressPac -- Nov. 19, 2008 7American Chemical Society's Weekly PressPac -- Nov. 19, 2008 8How do bacteria swim? Brown physicists explain 2Major conference on food Dec. 1-2, 2008 2Connecticut State Medical Society and Genomas Co Sponsor Forum on DNA Guided Medicine and the Path to Personalized Health Care 7888 1Connecticut State Medical Society and Genomas Co Sponsor Forum on DNA Guided Medicine and the Path to Personalized Health Care 7888 2World Alzheimer 26apos 3Bs Day 2008 Special Report 3A New Alzheimer Targets Take Center Stage 26688 1World Alzheimer 26apos 3Bs Day 2008 Special Report 3A New Alzheimer Targets Take Center Stage 26688 2Former Speaker of the House Newt Gingrich Featured Wednesday 7887 1Former Speaker of the House Newt Gingrich Featured Wednesday 7887 2PeopleClick LLC Provides Cutting Edge Servicing to Parents and Families 26683 1PeopleClick LLC Provides Cutting Edge Servicing to Parents and Families 26683 2
... natural chemicals, such as plant-derived triterpe... early molecular interactions can lead to cancer, ...d to stave off a variety of cancers. The latest st...s were presented at the American Association for C...search meeting today. , Trterpenoids and the rexi...
...ty of Illinois researcher reports that a red-winge...reased by 50 percent since 1972. The decrease is r...scillation which has resulted in warmer, wetter wi...trick Weatherhead put his 25-year data about the r... found a direct correlation with the North Atlanti...
...a protein that initiates a "quality control check"...those cells damaged during duplication. This knowl...ing anti-tumor drugs. The findings appear in the c...d a protein called cyclin-dependent kinase 2 (CDK2...s normal cells divide, they pause in the replicati...
...itute for International Health, in collaboration w...uckland, has revealed a 40% decline in the number ...Auckland, New Zealand over the past 25 years. The...alth care factors associated with an increase in h...t severe phase of the illness. , Stroke affects an...
Other Biology News:Plant-derived molecules, genetic manipulation point to future chemoprevention methods 2Plant-derived molecules, genetic manipulation point to future chemoprevention methods 3Plant-derived molecules, genetic manipulation point to future chemoprevention methods 4Plant-derived molecules, genetic manipulation point to future chemoprevention methods 5Climate change creates dramatic decline in red-winged black bird population 2Mayo discovers protein as potential tactic to prevent tumors 2New research shows big improvement in survival after stroke 2
HOXC11 Antibody
PPOX Immunogen: PPOX (AAH02357, 378 a.a. ~ 478 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region
Mouse monoclonal [SIT-01] to SIT ( Abpromise for all tested applications). entrezGeneID: 27240 SwissProtID: Q9Y3P8
Biology Products: